M. Merck, . Roche, . Bms, . Novartis, . Pfd et al., Déclaration de liens d'intérêts : DC déclare des liens d'intérêts potentiels : Board VIH France de Gilead jusqu'en 2015, consultant pour Innavirvax et Merck Switzerland, contrats de Janssen, MSD et ViiV, présentations pour Janssen et MSD. JPS déclare des liens d'intérêts potentiels : consultant ou adboard pour Gilead

P. Morlat, Prise en charge médicale des personnes vivant avec le VIH, Recommandations du groupe d'experts. Rapport, 2017.

P. Morlat, C. Roussillon, S. Henard, D. Salmon, F. Bonnet et al., Causes of death among HIV-infected patients in France in 2010 (national survey): trends since, AIDS, vol.28, issue.8, pp.1181-91, 2000.

, Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies, Lancet, vol.372, issue.9635, pp.293-302, 2008.

A. , Expanded European AIDS case definition, Lancet, vol.341, issue.8842, p.441, 1993.

E. Lanoy, J. Spano, F. Bonnet, M. Guiguet, F. Boué et al., The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study, Int J Cancer, vol.129, issue.2, pp.467-75, 2011.

M. Vandenhende, C. Roussillon, S. Henard, P. Morlat, E. Oksenhendler et al., Cancer-related causes of death among HIVinfected patients in France in 2010: evolution since, PloS One, vol.10, issue.6, p.129550, 2000.
URL : https://hal.archives-ouvertes.fr/hal-01289134

L. D. Rasmussen, M. T. May, G. Kronborg, C. S. Larsen, C. Pedersen et al., Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study, Lancet HIV, vol.2, issue.7, pp.288-98, 2015.

R. U. Hernández-ramírez, M. S. Shiels, R. Dubrow, and E. A. Engels, Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study, Lancet HIV, vol.4, issue.11, pp.495-504, 2017.

M. Hleyhel, M. Hleyhel, A. M. Bouvier, A. Belot, P. Tattevin et al., Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort, AIDS, vol.28, issue.14, pp.2109-2127, 2014.

C. Piketty, H. Selinger-leneman, A. Bouvier, A. Belot, M. Mary-krause et al., Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV, J Clin Oncol, vol.30, issue.35, pp.4360-4366, 2012.

M. Guiguet, F. Boué, J. Cadranel, J. Lang, E. Rosenthal et al., Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study, Lancet Oncol, vol.10, issue.12, pp.1152-1161, 2009.

J. M. Palefsky and E. A. Holly, Chapter 6: immunosuppression and co-infection with HIV, J Natl Cancer Inst Monogr, issue.31, pp.41-47, 2003.

A. E. Grulich, M. T. Van-leeuwen, M. O. Falster, and C. M. Vajdic, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis, Lancet, vol.370, issue.9581, pp.59-67, 2007.

M. J. Silverberg, C. Chao, W. A. Leyden, L. Xu, M. A. Horberg et al., HIV infection, immunodeficiency, viral replication, and the risk of cancer, Cancer Epidemiol Biomarkers Prev, vol.20, issue.12, pp.2551-2560, 2011.

E. A. Engels, M. V. Brock, J. Chen, C. M. Hooker, M. Gillison et al., Elevated incidence of lung cancer among HIV-infected individuals, J Clin Oncol, vol.24, issue.9, pp.1383-1391, 2006.

M. Helleberg, J. Gerstoft, S. Afzal, G. Kronborg, C. S. Larsen et al., Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV, AIDS, vol.28, issue.10, pp.1499-508, 2014.

S. R. Pine, L. E. Mechanic, L. Enewold, A. K. Chaturvedi, H. A. Katki et al., Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer, J Natl Cancer Inst, vol.103, issue.14, pp.1112-1134, 2011.

R. Valiathan, M. J. Miguez, B. Patel, K. L. Arheart, and D. Asthana, Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study, PloS One, vol.9, issue.5, p.97698, 2014.

L. Iordache, O. Launay, O. Bouchaud, V. Jeantils, C. Goujard et al., Autoimmune diseases in HIV-infected patients: 52 cases and literature review, Autoimmun Rev, vol.13, issue.8, pp.850-857, 2014.

A. Guihot, J. Cadranel, O. Lambotte, A. Lavolé, B. Autran et al., Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for non-small cell bronchial carcinoma

, Rev Mal Respir, vol.33, issue.6, pp.419-440, 2016.

A. Bourgarit, G. Carcelain, V. Martinez, C. Lascoux, V. Delcey et al., Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients, AIDS, vol.20, issue.2, pp.1-7, 2006.

S. Champiat, O. Lambotte, E. Barreau, R. Belkhir, A. Berdelou et al., Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper, Ann Oncol, vol.27, issue.4, pp.559-74, 2016.

J. B. Haanen, G. Carbonnel, F. Robert, C. Kerr, K. M. Peters et al., Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.28, issue.4, pp.119-161, 2017.

L. R. Cockerham, V. Jain, E. Sinclair, D. V. Glidden, W. Hartogenesis et al., Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease, AIDS, vol.28, issue.12, pp.1749-58, 2014.

C. L. Day, D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.443, issue.7109, pp.350-354, 2006.

L. Trautmann, L. Janbazian, N. Chomont, E. A. Said, S. Gimmig et al., Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction, Nat Med, vol.12, issue.10, pp.1198-202, 2006.

V. Velu, K. Titanji, B. Zhu, S. Husain, A. Pladevega et al., Enhancing SIV-specific immunity in vivo by PD-1 blockade, Nature, vol.458, issue.7235, pp.206-216, 2009.

F. Wightman, A. Solomon, S. S. Kumar, N. Urriola, K. Gallagher et al., Effect of ipilimumab on the HIV reservoir in an HIVinfected individual with metastatic melanoma, AIDS, vol.29, issue.4, pp.504-510, 2015.

A. Guihot, A. Marcelin, M. Massiani, A. Samri, C. Soulié et al., Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer
URL : https://hal.archives-ouvertes.fr/hal-02163559

, Ann Oncol, 2017.

C. L. Gay, R. J. Bosch, J. Ritz, J. M. Hataye, E. Aga et al., Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy, J Infect Dis, vol.215, issue.11, pp.1725-1758, 2017.